* LivaNova PLC LIVN.OQ reported quarterly adjusted
earnings of
73 cents per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of 58 cents. The mean expectation of eight analysts for the
quarter was for earnings of 64 cents per share. Wall Street
expected results to range from 59 cents to 74 cents per share.
* Revenue rose 13.3% to $286.10 million from a year ago;
analysts
expected $273.42 million.
* LivaNova PLC's reported EPS for the quarter was a loss
of 14
cents.
* The company reported a quarterly loss of $7.3 million.
* LivaNova PLC shares had fallen by 7.2% this quarter and
lost 11.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for LivaNova PLC is
$62.00
This summary was machine generated from LSEG data November 1 at
12:00 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.64 0.73 Beat
Jun. 30 2023 0.54 0.78 Beat
Mar. 31 2023 0.39 0.43 Beat
Dec. 31 2022 0.73 0.81 Beat